Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia.
Lugli A, Ebnoether M, Cogliatti SB, Gratwohl A, Passweg J, Hess U, Korte W, Hawle H, Tinguely M, Borisch B, Mach-Pascual S, Von Juergensonn S, Tichelli A, Dirnhofer S.
Lugli A, et al. Among authors: borisch b.
Hum Pathol. 2005 Jan;36(1):91-100. doi: 10.1016/j.humpath.2004.10.012.
Hum Pathol. 2005.
PMID: 15712187